Correction to: Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease: Using a Genetic Risk Score
- PMID: 38857334
- DOI: 10.1161/CIR.0000000000001262
Correction to: Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease: Using a Genetic Risk Score
Erratum for
-
Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial.Circulation. 2020 Feb 25;141(8):616-623. doi: 10.1161/CIRCULATIONAHA.119.043805. Epub 2019 Nov 11. Circulation. 2020. PMID: 31707849 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
